RELX Investor Day Presentation Deck

We fast-tracked review and dissemination of medical research, and enabled sharing in real time What did we do: 42,300 Covid-19 related articles published, including 2,800 content items in The Lancet (60 million downloads) and 900 articles in Cell Press ● Key research e.g. The Lancet first Covid-19 report 24 Jan 2020; 8 vaccine trials incl. AstraZeneca phase 2 and 3; T-cell response in Cell Press Set up The Lancet Covid-19 Commission, interdisciplinary initiative across the health sciences, business, finance, and public policy Organised China Covid-19 conference on virology, immunology, testing, therapeutics and public health; 1.1 million views • Collaboration with WHO to share early knowledge • All Covid-19 publications and tools made freely available on our Novel Coronavirus information centre Novel Coronavirus information Center ther's fee health and medical research on the novel (SARS Cand COVID CAPTOL HILL 10:43 AM RR language ressure find expert, curand infermation for the research and health community on SARS Chain) and COVO-hed) All information freely available on Novel Coronavirus information centre HOUSE HOLDS HEARING ON AUCI CORONAVIRUS RESPONSE Dr. Anthony Fauci holding up the copy of Cell Press during Congressional hearing¹ How did we do it: Mobilised our 26,000 editors to prioritise and flag Covid-19 articles ● Encouraged authors to upload Covid-19 preprints via dedicated portal for early knowledge dissemination Provided free language editing to China to accelerate work as early as January • Developed Covid-19 Relevancy Algorithm to help identify and prioritise Covid-19 research • The algorithm identifies articles dealing with Covid-19 diagnosis, treatment, vaccine development, virology, host-virus interaction, pandemic models and population statistics Changed our workflow to publish Covid-19 content within a record 53 days vs. average 125 days Source: (1) CNBC, The US National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci holds up a copy of a Cell paper as he testifies before a US House of Representatives committee on the Covid-19 response on July 31, 2020 & RELX 20

View entire presentation